Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2018 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (151)	6/23/2018 3:41:58 AM
From: A.J. Mullen	Read Replies (1) \| Respond to of 220

I have no objection. In real life, I got impatient waiting and sold my shares on the open market for slightly less than 45 Euro. That loss was more than compensated by avoiding the deterioration of the Euro in the last few months. But simple is good and transparent, so your method is probably best as well as economical. Ashley

To: BulbaMan who wrote (151)	6/29/2018 6:36:37 PM
From: BulbaMan	Read Replies (1) \| Respond to of 220

6/29/2018 Contest update Between ICE, SCOTUS and POTUS, there’s plenty to rant about this week. But, instead, I’ll “Let It Be” and post a link to this video: npr.org Meanwhile, the second quarter’s final week was a rough one for biotechs as well as the broad market. At Friday’s close, the Contest median was up 16.48% YTD (vs. up 23.15% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 2.88% YTD (vs. up 5.03% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 12.26% YTD (vs. up 16.91% YTD a week ago) and the Nasdaq Composite Index (IXIC), was up 8.79% YTD (vs. up 11.44% YTD a week ago). Contest leader KMASTR’s portfolio, up 74.37% YTD, bucked the bearish biotech bias and holding two of the week’s Top Five gainers actually gained ground. ALIAS’s portfolio, up 57.15% YTD, took back second place, while THID’s portfolio, up 53.03% YTD, moved into third place. At Friday's close, 48 of the 62 Contest portfolios were in the green, with 46 beating the NBI and 34 beating the SPSIBI. The 230 Contest stock picks have an average YTD gain of 8.22% and a median YTD loss of -5.76%, with 108 showing a gain for the year. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) I’ll post my usual end of quarter summary data shortly. Enjoy a relaxing pre-Independence Day weekend biotechies! Peace & good health, Bulba 6/29/18 Rank Name Profit/Loss 1 KMASTR 74,366 2 ALIAS 57,149 3 THID 53,027 4 ANDRE 51,071 5 MARKETH 49,936 6 MILJENKO45,563 7 JBOG 41,122 8 TRONKA 39,012 9 USUBAN 37,333 10 BIOADD 35,625 Week's Top 5 Gainers Symbol 6/22/18 6/29/18 Wk.%chg. GEMP 5.75 10.19 77.22% XLRN 37.37 48.52 29.84% XENE 7.70 9.20 19.48% ARQL 4.76 5.53 16.18% CARA 16.59 19.15 15.43% Week's Worst 5 Losers Symbol 6/22/18 6/29/18 Wk.%chg. MACK 9.15 4.91 -46.34% AVXL 3.92 2.62 -33.16% MRNA 0.910 0.625 -31.32% AKAO 12.42 8.66 -30.27% CWBR 8.31 6.55 -21.18%